Trials / Completed
CompletedNCT02053285
Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
Pilot Study of Dual-Energy Computed Tomography in Stage III Non-Small Cell Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Rush University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dual-energy CT (DECT) provides information on the blood volume in tumors and lymph nodes. As tumors respond to treatment, preliminary data suggests that the blood volumes changes as well. Investigators are therefore using DECT to test whether it can be used on radiation treatment to rapidly assess response to treatment.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2019-05-01
- Completion
- 2020-02-20
- First posted
- 2014-02-03
- Last updated
- 2022-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02053285. Inclusion in this directory is not an endorsement.